Table 2: Logistic Regression on the Association of MetS and VDD. MetS was used as outcome variable whereas vitD status was used as independent variable for individual risk outcomes describing MetS.
|
B
|
S.E.
|
Wald
|
df
|
p
|
OR |
95% C.I. for OR
|
|
Lower |
Upper |
|||||||
MetS |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
0.9 |
0.5 |
3 |
1 |
0.081 |
2.5 |
0.9 |
7.0 |
25(OH)D ≥10 ng/ml |
-0.2 |
0.1 |
2 |
1 |
0.133 |
0.8 |
0.7 |
1.1 |
25(OH)D ≥20 ng/ml |
-0.3 |
0.1 |
17 |
1 |
0.000 |
0.7 |
0.6 |
0.8 |
25(OH)D ≥30 ng/ml |
-0.1 |
0.1 |
1 |
1 |
0.370 |
0.9 |
0.7 |
1.1 |
WC |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
0.2 |
0.3 |
1 |
1 |
0.418 |
1.3 |
0.7 |
2.2 |
25(OH)D ≥10 ng/ml |
-0.5 |
0.1 |
41 |
1 |
0.000 |
0.6 |
0.5 |
0.7 |
25(OH)D ≥20 ng/ml |
-0.4 |
0.1 |
51 |
1 |
0.000 |
0.7 |
0.6 |
0.8 |
25(OH)D ≥30 ng/ml |
-0.2 |
0.1 |
5 |
1 |
0.024 |
0.8 |
0.7 |
1.0 |
HDL |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
0.1 |
0.3 |
0 |
1 |
0.791 |
1.1 |
0.6 |
2.0 |
25(OH)D ≥10 ng/ml |
-0.1 |
0.1 |
1 |
1 |
0.438 |
0.9 |
0.8 |
1.1 |
25(OH)D ≥20 ng/ml |
-0.1 |
0.1 |
5 |
1 |
0.029 |
0.9 |
0.8 |
1.0 |
25(OH)D ≥30 ng/ml |
-0.4 |
0.1 |
19 |
1 |
0.000 |
0.7 |
0.6 |
0.8 |
TG |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
0.6 |
0.6 |
1 |
1 |
0.335 |
1.8 |
0.5 |
6.3 |
25(OH)D ≥10 ng/ml |
0.3 |
0.1 |
5 |
1 |
0.029 |
1.4 |
1.0 |
1.8 |
25(OH)D ≥20 ng/ml |
0.1 |
0.1 |
2 |
1 |
0.123 |
1.2 |
1.0 |
1.4 |
25(OH)D ≥30 ng/ml |
0.1 |
0.1 |
0 |
1 |
0.554 |
1.1 |
0.8 |
1.4 |
FBG |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
0.3 |
0.4 |
1 |
1 |
0.463 |
1.4 |
0.6 |
3.3 |
25(OH)D ≥10 ng/ml |
0.0 |
0.1 |
0 |
1 |
0.785 |
1.0 |
0.8 |
1.3 |
25(OH)D ≥20 ng/ml |
-0.1 |
0.1 |
2 |
1 |
0.168 |
0.9 |
0.7 |
1.1 |
25(OH)D ≥30 ng/ml |
-0.2 |
0.1 |
3 |
1 |
0.109 |
0.8 |
0.7 |
1.0 |
BP |
|
|
|
|
|
|
|
|
25(OH)D ≥5 ng/ml |
1.0 |
0.4 |
5 |
1 |
0.022 |
2.8 |
1.2 |
6.6 |
25(OH)D ≥10 ng/ml |
-0.2 |
0.1 |
3 |
1 |
0.069 |
0.8 |
0.7 |
1.0 |
25(OH)D ≥20 ng/ml |
-0.1 |
0.1 |
5 |
1 |
0.029 |
0.9 |
0.8 |
1.0 |
25(OH)D ≥30 ng/ml |
0.0 |
0.1 |
0 |
1 |
0.856 |
1.0 |
0.8 |
1.2 |